KRAS and colorectal carcinoma: In this study, the prevalence of KRAS and BRAF mutations was investigated in 88 studies involving 25,527 CRC patients from various countries in Asia; the overall prevalence of KRAS gene mutations was found to be 36.3% (95% CI: 34.5-38.2).